Current unmet needs in locally advanced (unresectable) or metastatic dedifferentiated liposarcoma, the relevance of progression-free survival as clinical endpoint, and expectations for future clinical trial design: an international Delphi consensus report

Autor: Schöffski, P., Jones, R.L., Agulnik, M., Blay, J.Y., Chalmers, A., Italiano, A., Pink, D., Stacchiotti, S., Valverde, C., Vincenzi, B., Wagner, M.J., Maki, R.
Zdroj: In ESMO Open July 2024 9(7)
Databáze: ScienceDirect